1. Home
  2. IMAB vs VABK Comparison

IMAB vs VABK Comparison

Compare IMAB & VABK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IMAB
  • VABK
  • Stock Information
  • Founded
  • IMAB 2014
  • VABK 1998
  • Country
  • IMAB United States
  • VABK United States
  • Employees
  • IMAB N/A
  • VABK N/A
  • Industry
  • IMAB Biotechnology: Pharmaceutical Preparations
  • VABK Major Banks
  • Sector
  • IMAB Health Care
  • VABK Finance
  • Exchange
  • IMAB Nasdaq
  • VABK Nasdaq
  • Market Cap
  • IMAB 200.9M
  • VABK 201.8M
  • IPO Year
  • IMAB 2020
  • VABK N/A
  • Fundamental
  • Price
  • IMAB $4.87
  • VABK $37.69
  • Analyst Decision
  • IMAB Strong Buy
  • VABK
  • Analyst Count
  • IMAB 3
  • VABK 0
  • Target Price
  • IMAB $6.33
  • VABK N/A
  • AVG Volume (30 Days)
  • IMAB 4.2M
  • VABK 9.8K
  • Earning Date
  • IMAB 05-15-2025
  • VABK 07-24-2025
  • Dividend Yield
  • IMAB N/A
  • VABK 3.82%
  • EPS Growth
  • IMAB N/A
  • VABK 14.13
  • EPS
  • IMAB N/A
  • VABK 3.31
  • Revenue
  • IMAB N/A
  • VABK $56,012,000.00
  • Revenue This Year
  • IMAB N/A
  • VABK N/A
  • Revenue Next Year
  • IMAB N/A
  • VABK N/A
  • P/E Ratio
  • IMAB N/A
  • VABK $11.39
  • Revenue Growth
  • IMAB N/A
  • VABK 7.97
  • 52 Week Low
  • IMAB $0.60
  • VABK $33.66
  • 52 Week High
  • IMAB $5.90
  • VABK $44.00
  • Technical
  • Relative Strength Index (RSI)
  • IMAB 75.47
  • VABK 50.45
  • Support Level
  • IMAB $3.30
  • VABK $36.65
  • Resistance Level
  • IMAB $3.94
  • VABK $41.55
  • Average True Range (ATR)
  • IMAB 0.58
  • VABK 1.12
  • MACD
  • IMAB 0.23
  • VABK 0.19
  • Stochastic Oscillator
  • IMAB 76.12
  • VABK 22.02

About IMAB I-MAB

I-MAB is a clinical-stage biotech company. Along with its subsidiaries, it is principally engaged in discovering and developing transformational biologics in the fields of immuno-oncology and immuno-inflammation diseases in the People's Republic of China and other countries and regions. Its drug pipeline includes Uliledlimab (TJD5) which is an antibody for solid tumors, Ragistomig (TJ-L14B), and Givastomig (TJ-CD4B).

About VABK Virginia National Bankshares Corporation

Virginia National Bankshares Corp is a bank holding company which is engaged in the commercial and retail banking business. The bank offers a range of banking and related financial services, including checking accounts, negotiable order of withdrawal accounts, money market deposit accounts, certificates of deposit, individual retirement accounts and other depository services. Its segments include the Bank, VNB Trust and Estate Services, Sturman Wealth Advisors, and Masonry Capital. The Bank's commercial banking activities involve making loans, taking deposits and offering related services to individuals, businesses, and charitable organizations.

Share on Social Networks: